# Alefacept in Subjects With Chronic Plaque Psoriasis Who Failed to Respond to Anti-TNF Therapy

> **NCT00953329** · PHASE4 · TERMINATED · sponsor: **John Murray** · enrollment: 1 (actual)

## Conditions studied

- Chronic Plaque Psoriasis

## Interventions

- **DRUG:** alefacept

## Key facts

- **NCT ID:** NCT00953329
- **Lead sponsor:** John Murray
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-02
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Subjects declined enrollment; sponsor/PI elected to close study.
- **Last updated:** 2013-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00953329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00953329, "Alefacept in Subjects With Chronic Plaque Psoriasis Who Failed to Respond to Anti-TNF Therapy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00953329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*